July 15, 2025

Harmony Biosciences Holdings, Inc. (HRMY): Analyst Consensus Points to a 48.53% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a leading figure in the biotechnology sector, has been making waves with its innovative approach to treating rare and neurological diseases. With a market..

Apogee Therapeutics (APGE) Investor Outlook: 141% Potential Upside Sparks Interest in Biotech Stock

Apogee Therapeutics, Inc. (APGE) is capturing the attention of investors with its dynamic potential upside of 141.45%, highlighting significant opportunities within the high-stakes biotechnology sector. As a clinical-stage biotech firm..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 35.99% Potential Upside in the Healthcare Sector

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the competitive healthcare plans sector, offering a promising investment opportunity with a potential upside of 35.99%. Based in Orange, California, the company..

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 14.65% Potential Upside Amid Strong Revenue Growth

Phreesia, Inc. (NYSE: PHR) is gaining traction among investors, particularly those keen on the healthcare sector’s digital transformation. With a market capitalization of $1.64 billion, the company plays a pivotal..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Assessing a 107% Potential Upside in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the medical devices industry, is capturing investor attention with its significant potential upside. With an average target price suggesting a..

Amedisys Inc (AMED) Stock Analysis: Navigating the Healthcare Sector with a Forward P/E of 19.07

Amedisys Inc (NASDAQ: AMED), a key player in the healthcare sector, is garnering attention from investors seeking opportunities in the medical care facilities industry. Headquartered in Baton Rouge, Louisiana, Amedisys..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 69% Upside Potential in the Biotech Arena

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a pioneering force in the biotechnology sector, is captivating investor attention with its robust pipeline of neurological and psychiatric therapeutics. With a market capitalization of..

Evotec SE (EVO) Stock Analysis: A Glimpse into Its 47.51% Potential Upside

Evotec SE (NASDAQ: EVO) is a prominent player in the healthcare sector, specializing in drug discovery and development. With a market capitalization of $1.47 billion, this German-based company is a..

Liquidia Corporation (LQDA) Investor Outlook: Analyzing a 109% Upside Potential in the Biotech Space

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology sector, is garnering significant attention from investors due to its potential upside of 109.25%. Based in Morrisville, North Carolina, Liquidia..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a Potential 33.69% Upside in the Biotech Sector

Belite Bio, Inc (NASDAQ: BLTE) is making waves in the biotechnology sector, capturing the attention of investors with its innovative approach to tackling retinal degenerative diseases. Headquartered in San Diego,..

Perrigo Company plc (PRGO) Stock Report: Exploring a Potential 33% Upside in Healthcare

For investors with a keen interest in the healthcare sector, Perrigo Company plc (NYSE: PRGO) presents a compelling opportunity. Based in Dublin, Ireland, Perrigo operates as a powerhouse in the..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 178.67% Upside Potential in Biotech

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 178.67%, according to analyst target price estimates. Headquartered..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 28.75% Potential Upside in the Biotech Sector

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has emerged as a compelling proposition for investors within the biotechnology sector, boasting a market capitalization of $2.64 billion. This biopharmaceutical company, headquartered in Foster..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 3.83% Dividend Yield

For investors in the healthcare sector, Premier, Inc. (NASDAQ: PINC) presents a compelling study in contrasts. As a leading healthcare improvement company, Premier operates through its Supply Chain Services and..

Vericel Corporation (VCEL) Stock Analysis: A 49% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology industry, is currently capturing the attention of investors with its promising outlook. With a market capitalization of $2 billion, Vericel..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Landscape with a 20% Revenue Growth

Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology sector, continues to capture investor attention amid its strategic focus on oncology and immunology. Headquartered in Mechelen, Belgium, Galapagos is..

Immunocore Holdings plc (IMCR) Stock Analysis: Uncovering a 76% Potential Upside in Biotech

Immunocore Holdings plc (NASDAQ: IMCR) stands as a notable player in the biotechnology sector, a field known for its rapid innovation and potential for high returns. With a market capitalization..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: 30% Upside Potential Amid CNS Drug Innovations

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) presents a compelling opportunity for investors, driven by its strategic positioning in the biotechnology sector with a focus on central nervous system (CNS) disorders and..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 14.84% Potential Upside in the CNS Treatment Market

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company specializing in the treatment of central nervous system (CNS) diseases, presents an intriguing opportunity for investors with its robust product portfolio and..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking an 18% Potential Upside in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE) stands as a prominent player in the medical devices industry, specializing in hospital technology solutions that span from plasma collection to advanced surgical tools. With a..

Search

Funds

July 15, 2025

Search

Funds

July 15, 2025

FTSE 100

Funds